C. Walls

Infections from seven clinical trials of ixekizumab, an anti‐interleukin‐17A monoclonal antibody, in patients with moderate‐to‐severe psoriasis

B. Strober, M. Ohtsuki, K. Papp, 2017, The British journal of dermatology.

Cardiovascular safety - Update from up to 6 years of treatment with Baricitinib in Rheumatoid Arthritis clinical trials

M. Weinblatt, G. Burmester, P. Taylor, 2018 .

FRI0090 Analysis of neutrophils, lymphocytes, and platelets in pooled phase 2 and phase 3 studies of baricitinib for rheumatoid arthritis

J. Kremer, T. Huizinga, M. Issa, 2017 .